These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6188274)

  • 1. [Complex immunochemical examination of patients with some liver disorders].
    Petrunin DD; Molodenkov MN; Blagosklonov AS; Kuznetsov VN; Olefirenko GA
    Vopr Med Khim; 1983; 29(1):42-5. PubMed ID: 6188274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differential diagnostic importance of the immunochemical determination of blood serum, bile and urinary proteins in chronic liver and biliary tract diseases].
    Tsimmerman IaS; Vorona TV; Kevorkov NN
    Ter Arkh; 1980; 52(2):62-4. PubMed ID: 6769173
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rational liver diagnosis in the clinical laboratory].
    Teichmann W
    Z Gesamte Inn Med; 1966 Jul; 21(13):Suppl:160. PubMed ID: 5992843
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver function tests: analysis of AFP and ferritin].
    Takasaki K; Yamamoto M
    Rinsho Byori; 1986 Jun; 34 Spec No 67():67-72. PubMed ID: 2430123
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum alpha-fetoprotein in chronic liver disease.
    Weisz G; Udvardy M; Dalmi L; Kulcsár A
    Acta Med Hung; 1983; 40(2-3):155-64. PubMed ID: 6199736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma proteins in liver diseases as a diagnostic parameters].
    Rösler-Englhardt A
    Med Welt; 1975 Nov; 26(47):2125-30. PubMed ID: 53773
    [No Abstract]   [Full Text] [Related]  

  • 7. [A comparison of the individual alpha-fetoproteins of human fetuses and patients with primary liver cancer].
    Gusev AI; Iazova AK; Poliakova EV
    Biull Eksp Biol Med; 1971 Mar; 71(3):69-72. PubMed ID: 4327500
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complex immunochemical study of plasma proteins and soluble antigens of leukocytes in patients with ischemic heart disease during hemoperfusion therapy].
    Dmitriev AA; Shevchenko OP; Fomin AS; Petrunin DD
    Ter Arkh; 1985; 57(10):76-9. PubMed ID: 3936207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver function tests].
    Hankiewicz J; Bujniewicz E
    Wiad Lek; 1976 Aug; 29(15):1341-5. PubMed ID: 969516
    [No Abstract]   [Full Text] [Related]  

  • 10. [Judicious analysis of the differential diagnosis of liver diseases based on 16 variables].
    Lange HJ; Knick B; Hempel KJ; Prellwitz W
    Methods Inf Med Suppl; 1968; 3():201-11. PubMed ID: 5260779
    [No Abstract]   [Full Text] [Related]  

  • 11. [New methods for quantitative determination of plasma proteins and its clinical use].
    Rogos R
    Z Gesamte Inn Med; 1970 Mar; 25(6):233-40. PubMed ID: 5000494
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conventional laboratory diagnosis: what? when? how often? why?].
    Möller B; Heyne R
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S199-201. PubMed ID: 16435707
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammatory pseudotumor of the liver: demographics, diagnosis, and the case for nonoperative management.
    Koea JB; Broadhurst GW; Rodgers MS; McCall JL
    J Am Coll Surg; 2003 Feb; 196(2):226-35. PubMed ID: 12595051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bedside diagnosis: keypoints in nursing and interpretation of diagnostic data. Diagnosis of the digestive system (2) - liver and exocrine pancreas function tests].
    Monna T; Shirata K; Okuda K
    Kurinikaru Sutadi; 1982 Mar; 3(3):306-15. PubMed ID: 6918695
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic importance of alpha fetoproteins in oncology].
    Grob PJ; Dati F; Joller-Jemelka HI
    Ric Clin Lab; 1983; 13 Suppl 2():77-97. PubMed ID: 6199828
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of alphafetoprotein in liver diseases.
    Deshpande AD; Patil SD; Bansal MP; Choudhary AS; Talib SH
    Indian J Pathol Microbiol; 1986 Jul; 29(3):255-61. PubMed ID: 2434421
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumor markers in focal and diffuse liver diseases].
    Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
    Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
    Lamerz R; Runge M; Stieber P; Meissner E
    Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological examination in the diagnosis and monitoring of liver disease. Algorithms to aid the decision].
    Gerhardt MF; Guéchot J; Imbert-Bismut F; Jezequel-Cuer M; Lasnier E; Myara A; Vassault A; Vaubourdolle M; Voitot H; Calmus Y; Denninger MH; Lemoine A
    Pathol Biol (Paris); 1999 Nov; 47(9):1016-32. PubMed ID: 10609282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver function tests: analysis of serum protein fractions (including collagen reactions)].
    Miyaji T; Morishita M; Fukuda T; Kameoka M
    Rinsho Byori; 1986 Jun; 34 Spec No 67():58-66. PubMed ID: 3773279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.